Mode
Text Size
Log in / Sign up
N/A N=44 Randomized Other

Hospital-based Patient Navigation and Smoking Cessation

Smoking Cessation

Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcome: Primary: Number of Participants With Prescription for an FDA-approved Smoking Cessation Medication — 9; 11 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Patient Navigation (Behavioral); Enhanced Traditional Care (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Boston Medical Center
Primary completion
Jun 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Prescription for an FDA-approved Smoking Cessation Medication
9; 11
SECONDARY
Number of Participants With Self-reported Smoking Cessation
1; 2
SECONDARY
Number of Participants With Utilization of Smoking Cessation Medication
8; 7
SECONDARY
Number of Participants With Stage of Change for Smoking Cessation
3; 4
SECONDARY
Mean Fagerstrom Test Score for Nicotine Dependence
1.9; 3
SECONDARY
Use of Other Tobacco Treatment Support
0; 2

Summary

In a pilot randomized controlled trial (RCT), smokers hospitalized on the general internal medicine or family medicine service will be randomized to: 1) enhanced traditional care (ETC), or 2) patient navigation (PN). Patients will be assessed at 3 months for self-report of quitting, use of smoking cessation medications, and use of counseling in the outpatient setting. Medical charts will be reviewed to ascertain if a prescription for smoking cessation medications was sent to the participants' pharmacy (primary outcome), if participants received inpatient tobacco counseling from the Tobacco Treatment Service (TTS), and whether they had a diagnosis of mental health and substance use.

Eligibility Criteria

Inclusion Criteria

  • ≥ 18 years of age
  • Hospitalized on the General Internal Medicine or Family Medicine service
  • Have a primary care provider at BMC
  • Smoked ≥1 cigarettes/day in the past month
  • Must have plans to quit smoking
  • Read, understand, speak English
  • Possession of a telephone (home or cell)
  • Able to consent

Exclusion Criteria

  • Cannot give informed consent or participate in counseling due to psychiatric or cognitive impairment or communication barrier
  • Admitted to surgical, obstetric or psychiatric units
  • Estimated life expectancy of <12 months
  • Medical instability
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03452371). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search